ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa00500	Starch and sucrose metabolism	3/64	36/8135	0.002756	0.2893	0.2814	G6PC2/GBA3/HKDC1	3
KEGG	hsa04080	Neuroactive ligand-receptor interaction	8/64	353/8135	0.006143	0.3225	0.3136	GHRH/CORT/GABRP/GCGR/GABRA6/MTNR1A/PATE2/MC4R	8
KEGG	hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	2/64	24/8135	0.01504	0.515	0.5008	HS6ST3/HS3ST3B1	2
KEGG	hsa00052	Galactose metabolism	2/64	31/8135	0.02447	0.515	0.5008	G6PC2/HKDC1	2
KEGG	hsa04610	Complement and coagulation cascades	3/64	85/8135	0.02905	0.515	0.5008	C6/F12/MASP1	3
KEGG	hsa04742	Taste transduction	3/64	86/8135	0.02993	0.515	0.5008	PDE1B/TAS2R14/GABRA6	3
KEGG	hsa05032	Morphine addiction	3/64	91/8135	0.03457	0.515	0.5008	GABRP/PDE1B/GABRA6	3
KEGG	hsa05033	Nicotine addiction	2/64	40/8135	0.03924	0.515	0.5008	GABRP/GABRA6	2
KEGG	hsa04973	Carbohydrate digestion and absorption	2/64	47/8135	0.05252	0.6128	0.5959	G6PC2/HKDC1	2
KEGG	hsa00010	Glycolysis / Gluconeogenesis	2/64	67/8135	0.09733	0.783	0.7614	G6PC2/HKDC1	2
KEGG	hsa05218	Melanoma	2/64	72/8135	0.1098	0.783	0.7614	FGF17/FGF20	2
KEGG	hsa04020	Calcium signaling pathway	4/64	240/8135	0.1197	0.783	0.7614	PDE1B/FGF17/FGF20/CASQ1	4
KEGG	hsa00450	Selenocompound metabolism	1/64	17/8135	0.1258	0.783	0.7614	MARS2	1
KEGG	hsa00061	Fatty acid biosynthesis	1/64	18/8135	0.1327	0.783	0.7614	OLAH	1
KEGG	hsa04146	Peroxisome	2/64	82/8135	0.1359	0.783	0.7614	MPV17L2/PIPOX	2
KEGG	hsa00100	Steroid biosynthesis	1/64	20/8135	0.1463	0.783	0.7614	SOAT2	1
KEGG	hsa04530	Tight junction	3/64	169/8135	0.1474	0.783	0.7614	IGSF5/CLDN20/PARD6B	3
KEGG	hsa04727	GABAergic synapse	2/64	89/8135	0.1549	0.783	0.7614	GABRP/GABRA6	2
KEGG	hsa04658	Th1 and Th2 cell differentiation	2/64	92/8135	0.1632	0.783	0.7614	RBPJL/IL12RB2	2
KEGG	hsa05150	Staphylococcus aureus infection	2/64	96/8135	0.1743	0.783	0.7614	DEFA5/MASP1	2
KEGG	hsa04621	NOD-like receptor signaling pathway	3/64	184/8135	0.176	0.783	0.7614	DEFA5/PYDC1/CARD18	3
KEGG	hsa04010	MAPK signaling pathway	4/64	294/8135	0.2001	0.783	0.7614	RASGRP4/FGF17/FGF20/MAP3K6	4
KEGG	hsa04060	Cytokine-cytokine receptor interaction	4/64	295/8135	0.2017	0.783	0.7614	GDF10/IL12RB2/TNFSF18/CTF1	4
KEGG	hsa04744	Phototransduction	1/64	29/8135	0.205	0.783	0.7614	GNAT1	1
KEGG	hsa04922	Glucagon signaling pathway	2/64	107/8135	0.2057	0.783	0.7614	G6PC2/GCGR	2
KEGG	hsa03008	Ribosome biogenesis in eukaryotes	2/64	109/8135	0.2114	0.783	0.7614	MDN1/SPATA5	2
KEGG	hsa04015	Rap1 signaling pathway	3/64	210/8135	0.2286	0.783	0.7614	FGF17/PARD6B/FGF20	3
KEGG	hsa00051	Fructose and mannose metabolism	1/64	33/8135	0.2298	0.783	0.7614	HKDC1	1
KEGG	hsa00350	Tyrosine metabolism	1/64	36/8135	0.248	0.783	0.7614	TYR	1
KEGG	hsa01250	Biosynthesis of nucleotide sugars	1/64	37/8135	0.2539	0.783	0.7614	HKDC1	1
KEGG	hsa00260	Glycine, serine and threonine metabolism	1/64	40/8135	0.2714	0.783	0.7614	PIPOX	1
KEGG	hsa04014	Ras signaling pathway	3/64	232/8135	0.2752	0.783	0.7614	RASGRP4/FGF17/FGF20	3
KEGG	hsa05171	Coronavirus disease - COVID-19	3/64	232/8135	0.2752	0.783	0.7614	C6/RPS11/MASP1	3
KEGG	hsa04975	Fat digestion and absorption	1/64	43/8135	0.2886	0.783	0.7614	NPC1L1	1
KEGG	hsa04910	Insulin signaling pathway	2/64	137/8135	0.2932	0.783	0.7614	G6PC2/HKDC1	2
KEGG	hsa04151	PI3K-Akt signaling pathway	4/64	354/8135	0.3034	0.783	0.7614	G6PC2/FGF17/FGF20/LAMA5	4
KEGG	hsa03050	Proteasome	1/64	46/8135	0.3053	0.783	0.7614	PSMA8	1
KEGG	hsa04930	Type II diabetes mellitus	1/64	46/8135	0.3053	0.783	0.7614	HKDC1	1
KEGG	hsa05017	Spinocerebellar ataxia	2/64	143/8135	0.3107	0.783	0.7614	RBPJL/PSMA8	2
KEGG	hsa00520	Amino sugar and nucleotide sugar metabolism	1/64	49/8135	0.3217	0.783	0.7614	HKDC1	1
KEGG	hsa05224	Breast cancer	2/64	147/8135	0.3223	0.783	0.7614	FGF17/FGF20	2
KEGG	hsa04723	Retrograde endocannabinoid signaling	2/64	148/8135	0.3252	0.783	0.7614	GABRP/GABRA6	2
KEGG	hsa04979	Cholesterol metabolism	1/64	50/8135	0.3271	0.783	0.7614	SOAT2	1
KEGG	hsa05226	Gastric cancer	2/64	149/8135	0.3281	0.783	0.7614	FGF17/FGF20	2
KEGG	hsa00600	Sphingolipid metabolism	1/64	52/8135	0.3377	0.7879	0.7662	ENPP7	1
KEGG	hsa04630	JAK-STAT signaling pathway	2/64	162/8135	0.3655	0.7989	0.7769	IL12RB2/CTF1	2
KEGG	hsa04330	Notch signaling pathway	1/64	59/8135	0.3735	0.7989	0.7769	RBPJL	1
KEGG	hsa00310	Lysine degradation	1/64	63/8135	0.3932	0.7989	0.7769	PIPOX	1
KEGG	hsa04927	Cortisol synthesis and secretion	1/64	65/8135	0.4028	0.7989	0.7769	NR5A1	1
KEGG	hsa05321	Inflammatory bowel disease	1/64	65/8135	0.4028	0.7989	0.7769	IL12RB2	1
KEGG	hsa00970	Aminoacyl-tRNA biosynthesis	1/64	66/8135	0.4075	0.7989	0.7769	MARS2	1
KEGG	hsa04920	Adipocytokine signaling pathway	1/64	69/8135	0.4215	0.7989	0.7769	G6PC2	1
KEGG	hsa04924	Renin secretion	1/64	69/8135	0.4215	0.7989	0.7769	PDE1B	1
KEGG	hsa04622	RIG-I-like receptor signaling pathway	1/64	70/8135	0.4261	0.7989	0.7769	OTUD5	1
KEGG	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1/64	70/8135	0.4261	0.7989	0.7769	IGSF5	1
KEGG	hsa05230	Central carbon metabolism in cancer	1/64	70/8135	0.4261	0.7989	0.7769	HKDC1	1
KEGG	hsa04918	Thyroid hormone synthesis	1/64	75/8135	0.4485	0.8215	0.7989	DUOXA2	1
KEGG	hsa04740	Olfactory transduction	4/64	440/8135	0.4582	0.8215	0.7989	OR2W1/PDE1B/OR3A2/OR7A5	4
KEGG	hsa05130	Pathogenic Escherichia coli infection	2/64	197/8135	0.4616	0.8215	0.7989	MYO5C/CLDN20	2
KEGG	hsa05203	Viral carcinogenesis	2/64	204/8135	0.4799	0.828	0.8052	RBPJL/RANBP1	2
KEGG	hsa05165	Human papillomavirus infection	3/64	331/8135	0.4863	0.828	0.8052	RBPJL/PARD6B/LAMA5	3
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	2/64	212/8135	0.5003	0.828	0.8052	FGF17/FGF20	2
KEGG	hsa04512	ECM-receptor interaction	1/64	88/8135	0.5028	0.828	0.8052	LAMA5	1
KEGG	hsa04810	Regulation of actin cytoskeleton	2/64	218/8135	0.5153	0.828	0.8052	FGF17/FGF20	2
KEGG	hsa05222	Small cell lung cancer	1/64	92/8135	0.5185	0.828	0.8052	LAMA5	1
KEGG	hsa04713	Circadian entrainment	1/64	97/8135	0.5373	0.828	0.8052	MTNR1A	1
KEGG	hsa05215	Prostate cancer	1/64	97/8135	0.5373	0.828	0.8052	KLK3	1
KEGG	hsa04916	Melanogenesis	1/64	101/8135	0.5519	0.828	0.8052	TYR	1
KEGG	hsa05146	Amoebiasis	1/64	102/8135	0.5555	0.828	0.8052	LAMA5	1
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	1/64	106/8135	0.5695	0.828	0.8052	SOST	1
KEGG	hsa04931	Insulin resistance	1/64	108/8135	0.5763	0.828	0.8052	G6PC2	1
KEGG	hsa04066	HIF-1 signaling pathway	1/64	109/8135	0.5797	0.828	0.8052	HKDC1	1
KEGG	hsa05145	Toxoplasmosis	1/64	112/8135	0.5896	0.828	0.8052	LAMA5	1
KEGG	hsa04670	Leukocyte transendothelial migration	1/64	114/8135	0.5962	0.828	0.8052	CLDN20	1
KEGG	hsa04724	Glutamatergic synapse	1/64	114/8135	0.5962	0.828	0.8052	SHANK1	1
KEGG	hsa01200	Carbon metabolism	1/64	115/8135	0.5994	0.828	0.8052	HKDC1	1
KEGG	hsa04935	Growth hormone synthesis, secretion and action	1/64	119/8135	0.612	0.828	0.8052	GHRH	1
KEGG	hsa04152	AMPK signaling pathway	1/64	120/8135	0.6151	0.828	0.8052	G6PC2	1
KEGG	hsa04110	Cell cycle	1/64	126/8135	0.6332	0.8284	0.8056	CDC45	1
KEGG	hsa05020	Prion disease	2/64	273/8135	0.6385	0.8284	0.8056	C6/PSMA8	2
KEGG	hsa00230	Purine metabolism	1/64	128/8135	0.639	0.8284	0.8056	PDE1B	1
KEGG	hsa04068	FoxO signaling pathway	1/64	131/8135	0.6476	0.8293	0.8064	G6PC2	1
KEGG	hsa05322	Systemic lupus erythematosus	1/64	136/8135	0.6615	0.8368	0.8138	C6	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	1/64	142/8135	0.6774	0.8452	0.8219	HERC1	1
KEGG	hsa04514	Cell adhesion molecules	1/64	149/8135	0.6951	0.8452	0.8219	CLDN20	1
KEGG	hsa04934	Cushing syndrome	1/64	155/8135	0.7095	0.8452	0.8219	NR5A1	1
KEGG	hsa04390	Hippo signaling pathway	1/64	157/8135	0.7141	0.8452	0.8219	PARD6B	1
KEGG	hsa05160	Hepatitis C	1/64	157/8135	0.7141	0.8452	0.8219	CLDN20	1
KEGG	hsa03010	Ribosome	1/64	158/8135	0.7164	0.8452	0.8219	RPS11	1
KEGG	hsa04310	Wnt signaling pathway	1/64	167/8135	0.7362	0.8589	0.8353	SOST	1
KEGG	hsa04360	Axon guidance	1/64	182/8135	0.7663	0.8842	0.8598	PARD6B	1
KEGG	hsa05034	Alcoholism	1/64	187/8135	0.7756	0.8852	0.8608	SLC29A2	1
KEGG	hsa05202	Transcriptional misregulation in cancer	1/64	193/8135	0.7862	0.8856	0.8612	DEFA5	1
KEGG	hsa04510	Focal adhesion	1/64	201/8135	0.7996	0.8856	0.8612	LAMA5	1
KEGG	hsa05169	Epstein-Barr virus infection	1/64	202/8135	0.8012	0.8856	0.8612	RBPJL	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	1/64	222/8135	0.831	0.9089	0.8838	RANBP1	1
KEGG	hsa05131	Shigellosis	1/64	247/8135	0.8621	0.919	0.8937	HKDC1	1
KEGG	hsa05132	Salmonella infection	1/64	249/8135	0.8643	0.919	0.8937	RHOB	1
KEGG	hsa04144	Endocytosis	1/64	251/8135	0.8665	0.919	0.8937	PARD6B	1
KEGG	hsa05012	Parkinson disease	1/64	266/8135	0.8819	0.926	0.9004	PSMA8	1
KEGG	hsa05016	Huntington disease	1/64	306/8135	0.9149	0.9511	0.9249	PSMA8	1
KEGG	hsa05014	Amyotrophic lateral sclerosis	1/64	364/8135	0.9472	0.9738	0.947	PSMA8	1
KEGG	hsa05010	Alzheimer disease	1/64	384/8135	0.9553	0.9738	0.947	PSMA8	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	1/64	476/8135	0.9792	0.9823	0.9552	PSMA8	1
KEGG	hsa05168	Herpes simplex virus 1 infection	1/64	495/8135	0.9823	0.9823	0.9552	ZNF324	1